Results 221 to 230 of about 38,837 (270)

Low to moderate-dose off-label use of second-generation antipsychotics seems to be safe in the light of cardiac adverse effects in child psychiatric patients. [PDF]

Eur J Pediatr
Kakko K, Salmelin R, Puura K, Poutanen T.   +3 more
europepmc   +1 more source

High‐Dimensional Propensity Scores for Mitigating Confounding: Implementation Using Primary and Secondary Care Data in Hong Kong

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 2, February 2026.
ABSTRACT Purpose Confounding is a key concern in observational studies using healthcare databases. The high‐dimensional propensity score (HDPS) algorithm is an approach for generating and prioritising proxy variables, leveraging all available information in a database to mitigate residual confounding.
Edmund C. L. Cheung, Min Fan, Celine S. L. Chui, Angel Y. S. Wong, John Tazare   +4 more
wiley   +1 more source

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS). [PDF]

Clin Transl Sci
El Rouby N, Owusu-Obeng A, Preuss MH, Lee S, Shi M, Nadukuru R, Van Driest SL, Mosley JD, DelBello M.   +8 more
europepmc   +1 more source

Psychotropic Use Among Classroom Teachers in Espírito Santo: A Cross‐Sectional Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 2, February 2026.
ABSTRACT Purpose To assess the prevalence of psychotropic use among classroom teachers and to identify associated factors. Methods A cross‐sectional study was conducted between January and February 2024 in Espírito Santo, Brazil. The study included teachers from 20 state schools selected through probabilistic sampling.
Yohan Cancilheri Mazzini, Paulo Vitor Ramos Vitori, Kimberly Domingos Schneider, Gustavo Magno Baldin Tiguman, Kérilin Stancine Santos Rocha, Dyego Carlos Souza Anacleto de Araújo   +5 more
wiley   +1 more source

Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimation. [PDF]

Psychol Med
Feng Y, Wong KC, Leung PB, Lee BK, Sham PC, Lui SS, So HC.   +6 more
europepmc   +1 more source

C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 2, February 2026.
ABSTRACT Background Clozapine initiation often triggers inflammatory responses that can alter metabolism via Cytochrome P450 1A2 (CYP1A2) suppression. Although C‐reactive protein (CRP) is the recommended marker, it may be unavailable in community settings.
Nicoline Bihelek, Chad A. Bousman, William G. Honer, Reza Rafizadeh   +3 more
wiley   +1 more source

Comparative risk of QTc prolongation induced by second-generation antipsychotics in the real world: retrospective cohort study based on a hospital information system. [PDF]

BJPsych Open
He L, Yu W, Song H, Li L, Shen Y, Zhang L, Li H.   +6 more
europepmc   +1 more source

Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth [PDF]

, 2011
Tamara Pringsheim, Constadina Panagiotopoulos, Jana Davidson, Josephine Ho, The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group   +4 more
openalex   +1 more source

The Risk Factors and Mortality Among Patients With Different Combination Patterns of Opioids and Benzodiazepines: A Retrospective Study

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT The concurrent use of opioids and benzodiazepines (BZDs) has raised safety concerns due to increased risks of respiratory depression and death. To evaluate mortality risks linked to different patterns of co‐prescription, we conducted a retrospective cohort study using data from a private hospital system between 2008 and 2018.
Fang‐Yu Su, Ming‐Che Tsai, Yee‐Yung Ng, Shiao‐Chi Wu   +3 more
wiley   +1 more source

Consumers' and practitioners' perspectives on the antipsychotic induced metabolic syndrome and challenges in metabolic monitoring to patient prescribed second generation antipsychotics in severe mental illness. [PDF]

J Health Psychol
Poojari PG, Mey A, Khan SA, Shenoy S, Pai K, Shetty S, Bhat SM, Bhandary PV, Acharya LD, Bose S, Thunga G.   +10 more
europepmc   +1 more source